Figure S1.
BLI competition assays. Competition with well-characterized mAbs for the panel of eight IgG+ MBC-derived IgG mAbs. The timing of the exposure to each antibody is indicated with a black arrow for the well-characterized mAb and a red arrow for the MBC-derived mAb.